May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Biocompatibility and Visual Outcomes After Implantation of 1CU Accomodative Intraocular Lens in Patients With Fuchs’ Heterocromic Iridocyclitis
Author Affiliations & Notes
  • A. Bruscolini
    Dipartimento di Scienze Oftalmologiche, Università di Roma "La Sapienza", Rome, Italy
  • M. Accorinti
    Dipartimento di Scienze Oftalmologiche, Università di Roma "La Sapienza", Rome, Italy
  • F. Bozzoni-Pantaleoni
    Dipartimento di Scienze Oftalmologiche, Università di Roma "La Sapienza", Rome, Italy
  • M. P. Pirraglia
    Dipartimento di Scienze Oftalmologiche, Università di Roma "La Sapienza, Rome, Italy
  • A. Mastromatteo
    Dipartimento di Scienze Oftalmologiche, Università di Roma "La Sapienza", Rome, Italy
  • P. Pivetti-Pezzi
    Dipartimento di Scienze Oftalmologiche, Università di Roma "La Sapienza", Rome, Italy
  • Footnotes
    Commercial Relationships A. Bruscolini, None; M. Accorinti, None; F. Bozzoni-Pantaleoni, None; M.P. Pirraglia, None; A. Mastromatteo, None; P. Pivetti-Pezzi, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3916. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Bruscolini, M. Accorinti, F. Bozzoni-Pantaleoni, M. P. Pirraglia, A. Mastromatteo, P. Pivetti-Pezzi; Biocompatibility and Visual Outcomes After Implantation of 1CU Accomodative Intraocular Lens in Patients With Fuchs’ Heterocromic Iridocyclitis. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3916.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: to evaluate biocompatibility and visual outcomes after acrylic 1CU accomodative intraocular lens (IOL) implantation in unilateral Fuchs’ heterocromic iridocyclitis (FHI) - related cataract

Methods:: ten patients (3F,7M) aged 18 to 40 years (mean 32.6±6.48 years) with unilateral FHI and complicated cataract underwent phacoemulsification and 1CU accomodative IOL implantation. Main outcomes measures were: clinical course of FHI before and after surgery, uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), range of accomodation with subjective and objective (ultrasound biomicroscopy -UBM) methods, stereopsis and rate of complications were evaluated at time 7, 30, 180 days after surgery.

Results:: if compared with the preoperative reaction, chronic intraocular inflammation resulted unchanged at 30 and 180 days post-surgery. Seven days after surgery UDVA was ≥ 6/10 in 9 pts (90%), best corrected distance visual acuity (BCDVA) ≥ 8/10 in 9 pts (90%). Eight pts (80%) achieved an UNVA of J3 and 2 pts (20%) of J4.At 30 and 180 days the UDVA was ≥ 8/10 and BCDVA of 10/10 in 8 pts. Two patients showed BCDVA of 7/10 because of vitreal haze. Near visual acuity remained unchanged at days 30, while 180 days after surgery 60% had J2 or J3 UNVA and 90% J2 with or without near correction (mean: +1.5 diopter).Mean accomodation amplitude was 1.77±0.47 diopters (subjective near point) and mean decrease of ACD (UBM) was 0.6 ± 0.08 mm.A good stereopsis was achieved in all patients at 30 days and remained stable during the follow-up. At 180 days 2 pts (20%) developed posterior capsule opacification requiring YAG laser capsulotomy.

Conclusions:: The 1CU IOL implantation in young patients with unilateral FHI showed a good biocompatibility at medium term and provided satisfying visual rehabilitation in term of near visual acuity, accommodation and stereopsis

Keywords: uvea • cataract • treatment outcomes of cataract surgery 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×